Acknowledgements.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 6, p. 391, doi. 10.1177/1756285610391019
- Publication type:
- Article
Works matching IS 17562856 AND DT 2010 AND VI 3 AND IP 6
Results: 6
1
2
The role of pramipexole in a severe Parkinson’s disease model in mice.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 6, p. 333, doi. 10.1177/1756285610389655
- By:
- Publication type:
- Article
3
Quetiapine in the treatment of psychosis in Parkinson’s disease.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 6, p. 339, doi. 10.1177/1756285610389656
- By:
- Publication type:
- Article
4
Aminoglycoside-induced mutation suppression (stop codon readthrough) as a therapeutic strategy for Duchenne muscular dystrophy.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 6, p. 379, doi. 10.1177/1756285610388693
- By:
- Publication type:
- Article
5
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 6, p. 369, doi. 10.1177/1756285610388343
- By:
- Publication type:
- Article
6
Evolving expectations around early management of multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2010, v. 3, n. 6, p. 351, doi. 10.1177/1756285610385608
- By:
- Publication type:
- Article